BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, September 22, 2023
Home » Blogs » BioWorld Perspectives » Can't We Just Die Anymore?

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

Can't We Just Die Anymore?

May 19, 2011
By Michael Harris
No Comments

Everyone loved my grandmother. That's why they were rather relieved to hear she had died.

My grandmother spritely went about her business against the grain of at least six diseases and with the help of four surgeries, six prescription drugs and four medical devices after becoming a nonagenarian, but she also was mentally prepared for death, mainly because her joints, organs, bones, cells and her five senses were either abandoning or mocking her with frustrating and tormenting bouts of blindness, forgetfulness, ignored nerve center commands and pain . . . especially pain. She was putting up with a lot for the privilege to remain alive.

She was as active and full of life as any middle-aged woman one-third her age and she acknowledged that she had led a full and happy life. The only thing she complained about was the tardiness of Death.

"We can't just re-write the rules on death or the Grim Reaper will pass on while he's waiting for us to expire," she'd say. "Either these drug companies are making a fool of Death, or Death is fooling with all of us."

Which brings me to the new normal objective of life on drugs: to keep on living . . . forever!

Since the advent of the organized life sciences market more than a century ago, and increasingly since the 1976 addition of the biotechnology industry, humanity has been teasing Death with the old soul-on-a-string gag, faking mortality, and then yanking the dead herring away just as death stoops to claim it.

By 2025, my generation will be walking around like athletic zombies: sprightly bouncing around on titanium knees that could take us cross-country, but without the cognitive ability to find our way to the front door.

The world's population will increase by another 1 billion people by 2013 and is on target to increase to 10 billion by 2025. That's the equivalent of finding room for another China on the surface of the Earth every four years . . . only this time, this billion-member demographic may include members of the first born-immortal generation. We can keep people alive, but how do we feed, educate, employ or just stomach that many people? Face it! A gaggle of immortal vampire-ish citizens (at least vampires get to stay home during morning rush hour commutes) would be a millstone on society.

One day soon, we may cure death — then what? When I fantasized about my immortality, it was with visions of a muscular Superman, a suave Dracula and even a vivacious Jack LaLanne. Yes, I wanted immortality, but I wanted it stuck on age 45! Well, we're getting our wish, but the bio-genie has tricked us . . . we forgot to ask to stop aging!

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Sept. 22, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for September 22, 2023.
  • Hands holding torn contract

    Quite a fix: Orthofix sacks three top execs

    BioWorld MedTech
    Orthofix Medical Inc. terminated its CEO, chief financial officer and chief legal officer in a move that plunged the stock from $18.63 at Monday’s close to $13.01...
  • New NLRP3 inflammasome inhibitors named in PTC Therapeutics patent

    BioWorld Science
    PTC Therapeutics Inc. has patented new NLRP3 inflammasome inhibitors reported to be useful...
  • Illustration of Alzheimer’s in the brain.

    Study identifies cause of death for Alzheimer’s neurons

    BioWorld
    By creating a new mouse model of Alzheimer’s disease that better recapitulated how the disease plays out in humans, investigators at KU Leuven have gained new...
BioFuture ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing